Preclinical Cancer Research in the Age of Reduced Animal Use & Artificial Intelligence
- Selecting human-relevant models based on genomic, phenotypic, and clinical alignment to enhance translational accuracy
- Aligning model selection and study endpoints with evolving regulatory guidelines
- Leveraging AI to guide model selection, predict drug response, and inform combination and biomarker strategies for regulatory-ready studies